Morgan Stanley 13D and 13G filings for Chemomab Therapeutics Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-07 4:21 pm Sale | 2025-07-31 | 13G | Chemomab Therapeutics Ltd. CMMB | MORGAN STANLEY MS | 13,213,260 3.200% | -19,069,420 (-59.07%) | Filing |
| 2025-08-07 11:45 am Purchase | 2025-06-30 | 13G | Chemomab Therapeutics Ltd. CMMB | MORGAN STANLEY MS | 32,282,680 8.400% | 32,282,680 (New Position) | Filing |